TickerFacts.

Ceribell, Inc. (CBLL): Capital Expenditures

Annual figures by period end, from SEC filings.

$767.0K
Year ended 2025-12-31
$690.0K
Trailing 12 months to 2026-06-30
$1.34M2023-12-31: $983.0K2024-12-31: $1.34M2025-12-31: $767.0K$767.0K
2023-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$767.0K-42.8%2026-02-24, From 2025-01-01
2024-12-31$1.34M+36.3%2026-02-24, From 2024-01-01
2023-12-31$983.0Kn/a2025-02-25, From 2023-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Ceribell, Inc. (CBLL)2025-12-31$767.0K-42.8%
Biolife Solutions Inc (BLFS)2025-12-31$9.48M+193.7%
Electromed, Inc. (ELMD)2026-06-30$1.25M+377.9%
Outset Medical, Inc. (OM)2025-12-31$798.0K-12.5%
Iridex Corp (IRIX)2026-01-03$143.0K+1000.0%
Axogen, Inc. (AXGN)2025-12-31$3.75M+20.8%
Stereotaxis, Inc. (STXS)2025-12-31$93.0K+173.5%
electroCore, Inc. (ECOR)2025-12-31$66.0Kn/a
InMode Ltd. (INMD)2025-12-31$972.0K+45.3%

Compare CBLL, BLFS, ELMD, OM side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗